The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Poliovirus Vaccine Market Research Report 2024
Synopsis
Polio vaccines are vaccines used to prevent poliomyelitis (polio).
The global Poliovirus Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 955.4 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine.
Report Scope
The Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Polio vaccines are vaccines used to prevent poliomyelitis (polio).
The global Poliovirus Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 955.4 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine.
Report Scope
The Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Poliovirus Vaccine Market Overview
1.1 Product Overview and Scope of Poliovirus Vaccine
1.2 Poliovirus Vaccine Segment by Type
1.2.1 Global Poliovirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Poliovirus Vaccine Segment by Application
1.3.1 Global Poliovirus Vaccine Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliovirus Vaccine Revenue 2019-2030
1.4.2 Global Poliovirus Vaccine Sales 2019-2030
1.4.3 Global Poliovirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poliovirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Poliovirus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
2.7 Poliovirus Vaccine Market Competitive Situation and Trends
2.7.1 Poliovirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poliovirus Vaccine Players Market Share by Revenue
2.7.3 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliovirus Vaccine Retrospective Market Scenario by Region
3.1 Global Poliovirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poliovirus Vaccine Global Poliovirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Poliovirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Poliovirus Vaccine Sales by Region: 2025-2030
3.3 Global Poliovirus Vaccine Global Poliovirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Poliovirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Poliovirus Vaccine Revenue by Region: 2025-2030
3.4 North America Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poliovirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Poliovirus Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Poliovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poliovirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Poliovirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliovirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poliovirus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Poliovirus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poliovirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Poliovirus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poliovirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poliovirus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poliovirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Poliovirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Poliovirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Poliovirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Poliovirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Poliovirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Poliovirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Poliovirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Poliovirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poliovirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Poliovirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Poliovirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Poliovirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Poliovirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Poliovirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Poliovirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Poliovirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Poliovirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Poliovirus Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Poliovirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Poliovirus Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Poliovirus Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Poliovirus Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IMBCA Poliovirus Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Poliovirus Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliovirus Vaccine Industry Chain Analysis
7.2 Poliovirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliovirus Vaccine Production Mode & Process
7.4 Poliovirus Vaccine Sales and Marketing
7.4.1 Poliovirus Vaccine Sales Channels
7.4.2 Poliovirus Vaccine Distributors
7.5 Poliovirus Vaccine Customers
8 Poliovirus Vaccine Market Dynamics
8.1 Poliovirus Vaccine Industry Trends
8.2 Poliovirus Vaccine Market Drivers
8.3 Poliovirus Vaccine Market Challenges
8.4 Poliovirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
